Loki Therapeutics Announces Seed Financing to Develop Therapeutics that Enhance Longevity and Treat Immune-system Related Diseases

LONG ISLAND CITY, N.Y., Jan. 25, 2022 /PRNewswire/ — Loki Therapeutics, a company developing next- generation therapeutics that leverage vaccination recall antigens to enhance longevity and treat immune-system related diseases, including cancer, today announced that it has secured seed…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.